Table 2.
Percentage of patients who received RT in various dental areas in bilateral neck.
| Exceeding 40 Gy D₂% Dmean dose range (Gy) |
||||||
|---|---|---|---|---|---|---|
| Primary (n) | Maxillary incisors, canines | Maxillary right premolars, molars | Maxillary left premolars, molars | Mandibular incisors, canines | Mandibular right premolars, molars | Mandibular left premolars, molars |
| Oropharynx (27) |
44% 2.7–71.4 |
67% 4.3–70.3 |
70% 7.8–71.8 |
67% 29.2–71.9 |
78% 23.8–70.2 |
89% 25.3–73.3 |
| Oral cavity (20) |
65% 12.3–68.7 |
59% 11.3–70.8 |
76%a 16.2–70.2 |
90% 28.0–69.2 |
94%b 11.1–69.7 |
100% 43.7–68.9 |
| Larynx (8) |
0% 1.1–38.7 |
12.5% 1.8–49.4 |
0% 1.7–34.3 |
12.5% 20.0–44.0 |
25% 20.6–50.5 |
37.5% 24.9–49.2 |
| Hypopharynx (6) |
0% 0.2–31.7 |
0% 0.3–33.2 |
0% 0.3–28.1 |
17% 0.5–45.2 |
50% 0.8–60.3 |
33% 0.9–63.8 |
| Nasopharynx (4) |
50% 23.0–53.9 |
50% 27.0–58.9 |
100% 45.3–56.1 |
0% 0.5–36.7 |
50% 0.5–50.1 |
50% 0.5–42.2 |
| Nasal cavities (6) |
100% 50.6–72.9 |
67% 3.7–67.8 |
67% 5.9–72.5 |
0% 0.3–29.1 |
17% 0.3–42.5 |
33% 0.2–53.55 |
aThree patients could not be delineated.
bTwo patients could not be delineated.